Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
01/03/1995 | US5378464 Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140 |
01/03/1995 | US5378460 Plants |
01/03/1995 | US5378457 Immunology, genetic engineering |
01/03/1995 | US5378365 Process for the isolation of highly purified factors IX, X and II from prothrombin complex or human plasma |
01/02/1995 | CA2127230A1 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic cholesterol esterase |
01/02/1995 | CA2125344A1 Encapsidated recombinant poliovirus nucleic acid and methods of making and using same |
12/31/1994 | CA2127068A1 Process for the preparation of native human glicentin |
12/28/1994 | EP0630969A1 Vectors containing nucleotide sequences of a plasmid isolated from Lactobacillus curvatus, proteins coded by the genome of these vectors, and the use of such vectors in processes for the production of polypeptides |
12/28/1994 | EP0630968A2 Genetic selection of proteins able to bind a ligand by signal-transduction in a microorganism |
12/28/1994 | EP0630410A1 Method of production of poly-beta-hydroxyalkanoate copolymers |
12/28/1994 | EP0630409A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
12/28/1994 | EP0630407A1 Anti-viral fusion peptides |
12/28/1994 | EP0630405A1 Novel V28 seven transmembrane receptor |
12/28/1994 | EP0630404A1 Protein compound capable of inhibiting tumoral growth |
12/28/1994 | EP0630385A1 Potent peptide for stimulation of cytotoxic t lymphocytes specific for the hiv-1 envelope |
12/28/1994 | EP0630384A1 Methods and compounds for prevention of graft rejection |
12/28/1994 | EP0630383A1 Methods of treating diabetes |
12/28/1994 | EP0630265A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION |
12/28/1994 | EP0630264A1 Ligands for improving metal chelate formation kinetics |
12/28/1994 | EP0630258A1 Vaccine for susceptible hosts against nonadapted parasites |
12/28/1994 | EP0630257A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
12/28/1994 | EP0630255A1 Mhc conjugates useful in ameliorating autoimmunity |
12/28/1994 | EP0561821B1 Method of producing collagen particles, and the use of such particles as substrates for active substances |
12/28/1994 | EP0527814B1 An immortalized primate hepatocyte cell line |
12/28/1994 | EP0413818B1 Process for producing a human neutrophil chemotactic factor polypeptide |
12/28/1994 | EP0346429B1 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
12/28/1994 | EP0248887B1 Cell-free t cell antigen receptor and its clinical utilities |
12/28/1994 | CN1096822A Improved methods for the preparation of endotoxinbinding proteins |
12/28/1994 | CN1096821A BPI-immunoglobulin fusion proteins |
12/28/1994 | CN1027179C Method of using bari for secreting foreign proteins |
12/28/1994 | CN1027136C Wound healing |
12/27/1994 | US5376639 Treatment of sarcoma with interleukin 1α polypeptides |
12/27/1994 | US5376635 Fluorine containing atrial natriuretic peptides |
12/27/1994 | US5376631 Oxidation products containing the D-region of fibrinogen with methionine residues which have been oxidized to methionine sulfoxide, as stimulants for plasminogen activators |
12/27/1994 | US5376567 Expression of interferon genes in Chinese hamster ovary cells |
12/27/1994 | US5376546 Analogs of ribosome-inactivating proteins |
12/27/1994 | US5376542 Method for producing immortalized cell lines using human papilluma virus genes |
12/27/1994 | US5376530 Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor |
12/27/1994 | US5376525 Method for detection of mycoplasma |
12/27/1994 | US5376373 Method of inhibiting radiation induced weight and hair loss |
12/27/1994 | US5376370 Vaccine for malaria |
12/27/1994 | US5376367 Fusion proteins comprising MGF and IL-3 |
12/25/1994 | CA2126619A1 Sustained-release preparation of anti-endothelin substance |
12/23/1994 | CA2126359A1 Preparation and screening of highly diverse peptide libraries for binding activity |
12/22/1994 | WO1994029729A1 Method and analytical device for simultaneous immunoassay |
12/22/1994 | WO1994029727A1 Inhibiting protein interactions |
12/22/1994 | WO1994029720A1 Leukocyte adhesion assay |
12/22/1994 | WO1994029522A1 Paper strengthened with solubilized collagen, and method for making the same |
12/22/1994 | WO1994029487A1 Compositions and methods for inhibiting replication of human immunodeficiency virus-1 |
12/22/1994 | WO1994029486A1 Method for generation of sequence sampled maps of complex genomes |
12/22/1994 | WO1994029482A1 5' nucleases derived from thermostable dna polymerase |
12/22/1994 | WO1994029479A1 Oligonucleotides which inhibit hiv protease function |
12/22/1994 | WO1994029472A2 Mengovirus as a vector for expression of foreign polypeptides |
12/22/1994 | WO1994029471A1 Adenoviral vectors for treatment of hemophilia |
12/22/1994 | WO1994029470A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
12/22/1994 | WO1994029469A2 Plasmids suitable for gene therapy |
12/22/1994 | WO1994029468A1 Untranslated exon-1 sequences of eukaryotic genes as promoters |
12/22/1994 | WO1994029467A2 Methods and compositions for modulating lipid content of plant tissues |
12/22/1994 | WO1994029463A1 Yeast promotor and use thereof |
12/22/1994 | WO1994029462A1 Multicistronic expression of recombinant genes in bacterial cells |
12/22/1994 | WO1994029459A1 Stress proteins and uses therefor |
12/22/1994 | WO1994029458A1 Hybrid receptor molecules |
12/22/1994 | WO1994029457A2 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
12/22/1994 | WO1994029450A2 Novel, recombinantly produced spider silk analogs |
12/22/1994 | WO1994029449A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
12/22/1994 | WO1994029448A1 Dna and protein coded for thereby |
12/22/1994 | WO1994029447A2 Dna coding for the human thyrotropin-releasing hormone receptor |
12/22/1994 | WO1994029444A1 Method for treating kaposi's sarcoma with antisense oligonucleotides |
12/22/1994 | WO1994029442A2 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
12/22/1994 | WO1994029440A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
12/22/1994 | WO1994029438A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
12/22/1994 | WO1994029436A1 Methods for selectively stimulating proliferation of t cells |
12/22/1994 | WO1994029435A1 Enhanced expression of protein by using culture medium containing membrane lipids |
12/22/1994 | WO1994029350A2 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
12/22/1994 | WO1994029349A1 Trifunctional antithrombin and antiplatelet peptides |
12/22/1994 | WO1994029346A1 IDENTIFICATION OF THE ADHESIN GENE FROM $i(M. PIRUM) |
12/22/1994 | WO1994029345A1 Mutant dna encoding insulin receptor substrate 1 |
12/22/1994 | WO1994029344A1 Super proteins including interferons and interleukins |
12/22/1994 | WO1994029343A1 CLONING AND USES OF THE GENETIC LOCUS bcl-6 |
12/22/1994 | WO1994029342A1 Cell surface lamp expression and selectin-dependent adhesion |
12/22/1994 | WO1994029341A1 Methods of enhancing bioactivity of chemokines |
12/22/1994 | WO1994029340A1 Human-origin tumor cell proliferation inhibiting factor |
12/22/1994 | WO1994029339A1 Tandem synthetic hiv-1 peptides |
12/22/1994 | WO1994029338A1 Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists |
12/22/1994 | WO1994029333A1 Immunoreactive reagents employing monoamine oxidase |
12/22/1994 | WO1994029332A1 Coiled-coil stem loop templates |
12/22/1994 | WO1994029330A1 Myeloid cell leukemia associated gene mcl-1 |
12/22/1994 | WO1994029329A1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids |
12/22/1994 | WO1994028942A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION |
12/22/1994 | WO1994028938A1 Adenovirus vectors for gene therapy sponsorship |
12/22/1994 | WO1994028931A1 Methods for treating inflammatory disorders |
12/22/1994 | WO1994028930A1 Malaria recombinant poxvirus vaccine |
12/22/1994 | WO1994028929A1 Hiv envelope polypeptides |
12/22/1994 | WO1994028928A1 Novel attenuated pseudomonas aeruginosa strains |
12/22/1994 | WO1994028921A1 Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides |
12/22/1994 | WO1994028920A1 Synthetic peptide inhibitors of hiv transmission |
12/22/1994 | WO1994028917A1 Pharmaceutical formulations |
12/22/1994 | WO1994028916A1 Release and mobilisation of haematopoietic cells |
12/22/1994 | WO1994028915A1 Hiv retrovirus infection inhibitor capable of interacting with cd26 receptor |
12/22/1994 | WO1994028912A1 Cd28 pathway immunosuppression |